
News • Research on RAD51 biomarker
Next-generation sequencing for personalizing prostate cancer treatment
Certain gene alterations can serve as a prognostic and predictive biomarker for prostate cancer. Now, researchers confirm the feasibility of using NGS on this marker for precise patient stratification and treatment selection.